Recent Articles from Benzinga
Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Website: https://www.benzinga.com
Nvidia CEO Jensen Huang once celebrated a company milestone with a tattoo. Investors who bought the stock after the tattoo image surfaced have been pleasantly rewarded.
Via Benzinga · July 29, 2025
Teva anticipates EBITDA recovery post-2025 as Austedo and Uzedy grow and generic Revlimid faces rising competition.
Via Benzinga · July 29, 2025
Universal Health Services beat Q2 earnings and raised full-year guidance, but growth concerns in behavioral health weighed on the core performance.
Via Benzinga · July 29, 2025
Tapestry slips as BofA downgrades on margin concerns and tempered FY26 growth outlook, despite continued strength at Coach.
Via Benzinga · July 29, 2025
Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via Phase 3 trials.
Via Benzinga · July 29, 2025
American Tower slips as steady Q2 results and 2025 guidance spark a cautious, wait-and-see investor stance.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Broadcom (AVGO) leads the ASIC market, supplying custom chips for high-performance computing. U.S. policy shifts and AI demand provide tailwinds for peers AMD and Nvidia.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
PTC Therapeutics secures FDA approval for Sephience in PKU, launching August with analysts projecting strong revenue and broad patient impact.
Via Benzinga · July 29, 2025
Bitcoin (CRYPTO: BTC) and other cryptocurrencies continue to trade sideways ahead of Wednesday’s Federal Open Market Committee meeting, though pundits expect volatility to pick up soon.
Via Benzinga · July 29, 2025
Lucid shares dip as branding push with Timothée Chalamet collides with rising robotaxi competition and investor caution.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Spotify (SPOT) stock drops after missing earnings and revenue expectations, despite strong user growth. Analysts maintain Overweight and Buy ratings.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Advanced Micro Devices Inc. (NASDAQ: AMD) shares are trading higher Tuesday extending momentum from Monday after reports revealed the company raised the price of its MI350 artificial intelligence chip.
Via Benzinga · July 29, 2025
Standard Chartered Bank says Ethereum (CRYPTO: ETH)-focused corporate treasuries have already purchased 1% of all ETH in just two months and could grow to own as much as
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.
Via Benzinga · July 29, 2025
Risk appetite took a breather Tuesday, with major U.S. stock indices retreating modestly from record highs as investors braced for a pivotal stretch of earnings and macro events.
Via Benzinga · July 29, 2025
Shares of autonomous driving firm Pony AI are trading lower Tuesday. The company announced Monday it secured a permit for driverless robotaxi services in Shanghai.
Via Benzinga · July 29, 2025
Kuvi.ai has raised $700,000 in seed funding to support the private beta launch of its Agentic Finance Operating System, a text-based crypto interface designed to simplify digital asset transactions.
Via Benzinga · July 29, 2025
Li Auto launches Li i8 six-seat battery electric SUV, expanding EV lineup. Features advanced safety systems, fast charging, and AI-powered agent.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Microsoft has beaten revenue and earnings per share estimates from analysts in the last nine straight quarters. Investors look for another beat and strength in AI and cloud.
Via Benzinga · July 29, 2025
Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, with more data expected.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Sysco beat Q4 earnings and sales estimates, but shares slipped as its FY2026 EPS guidance came in below expectations.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
The stock of Cadence Design Systems Inc (CDNS) rallied after it reported upbeat Q2 earnings and raised its 2025 outlook. Analysts are optimistic.
Via Benzinga · July 29, 2025
Corning Inc reported strong Q2 results, beating expectations with 12% sales growth and 28% increase in EPS. Springboard plan driving success.
Via Benzinga · July 29, 2025